Safety and tolerability of duloxetine in women with stress urinary incontinence

BJOG : an International Journal of Obstetrics and Gynaecology
M OelkeM C Michel

Abstract

The serotonin/noradrenaline uptake inhibitor duloxetine has been shown to be effective in the medical treatment of stress urinary incontinence (SUI) in women. To review the safety and tolerability of duloxetine with SUI. A systematic Medline search for the key word "duloxetine" was performed, and abstracts from recent international gynaecological and urological meetings were also considered. Various unpleasant adverse effects exist, among which nausea is the most frequent, but is mild to moderate and transient in most cases. Dose escalation upon initiation of treatment improves the tolerability of duloxetine. The use of duloxetine appears safe as it lacks the cardiovascular adverse effects of older amine reuptake inhibitors. Duloxetine has an acceptable safety profile. Dose escalation combined with patient counselling on the intensity and transient nature of adverse effects may help to further improve the benefit/tolerability ratio of duloxetine in the treatment of SUI.

References

Feb 9, 2000·Journal of Clinical Pharmacology·A SharmaB J Cerimele
Apr 3, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J E TurcotteP Blier
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Peggy A NortonUNKNOWN Duloxetine Urinary Incontinence Study Group
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stephan A ChalonWilliam Z Potter
Sep 23, 2003·The Journal of Urology·Roger R DmochowskiUNKNOWN Duloxetine Urinary Incontinence Study Group
Feb 7, 2004·BJU International·R J MillardUNKNOWN Duloxetine UI Study Group
Feb 14, 2004·BJOG : an International Journal of Obstetrics and Gynaecology·Philip van KerrebroeckUNKNOWN Duloxetine Urinary Incontinence Study Group
Jul 16, 2004·The Journal of Pharmacology and Experimental Therapeutics·Smriti IyengarRosa Maria A Simmons
Jul 16, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Lars ViktrupNorman R. Zinner
Aug 4, 2004·Psychopharmacology·Stephan ChalonLuc-André Granier
Sep 2, 2004·Obstetrics and Gynecology·Linda CardozoRichard C Bump
Dec 23, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Lars ViktrupAndre Tylee
Jan 22, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Kraig S KinchenRalph Swindle
Mar 2, 2005·Journal of Clinical Psychopharmacology·Michael E ThaseMichael J Detke
Apr 12, 2005·The Journal of Urology·Gamal M GhoniemUNKNOWN Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group
May 17, 2005·Drugs·Sue Wilson, Spilios Argyropoulos
Jun 2, 2005·Pain·David J GoldsteinSmriti Iyengar
Aug 12, 2008·Current Drug Safety·Martin C MichelMatthias Oelke
Nov 1, 2005·Women's Health·Martin C Michel, Matthias Oelke

❮ Previous
Next ❯

Citations

May 17, 2011·Indian Journal of Pharmacology·P DeepakT K Sen
Jul 1, 2014·Female Pelvic Medicine & Reconstructive Surgery·Lucio M A CipulloMaurizio Guida
May 7, 2011·Expert Opinion on Drug Safety·Istvan BitterPal Czobor
Nov 26, 2009·Current Medical Research and Opinion·Linda CardozoYan D Zhao
Mar 18, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·E CastelA de la Taille
Jul 17, 2007·The Journal of Urology·Israel Franco
Feb 15, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·P M LattheK Khan
Sep 1, 2013·Lower Urinary Tract Symptoms·Ryuji SakakibaraNobuo Kuroki
May 1, 2012·Lower Urinary Tract Symptoms·Takashi ItoTatsuya Yamamoto
Aug 4, 2012·Pediatric Clinics of North America·Israel Franco
Feb 15, 2018·American Journal of Physiology. Renal Physiology·Takahisa SuzukiNaoki Yoshimura
Feb 1, 2020·Expert Opinion on Pharmacotherapy·Sunny TrivediC Thomas Vangsness
Feb 4, 2010·Acta Obstetricia Et Gynecologica Scandinavica·Steinar Hunskaar, Lina Kristin Welle-Nilsen
Jun 15, 2007·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.